CD8A and COVID-19: To identify immunological parameters differentially expressed in circulating immune cells of COVID-19 patients with MD or SD, we evaluated the expression of activation/exhaustion surface markers, intracellular cytokines, and cytotoxicity-associated molecules in B lymphocytes, CD4+ and CD8+ T cells.